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Adrenal myelolipoma is an uncommon, non-functioning
tumor composed of variable amounts of mature adipose
tissue and scattered islands of hematopoietic elements,
including erythroid, myeloid, lymphoid series, and mega-
karyocytes. Diagnosis of adrenal myelolipomas based on
radiologic imaging, such as ultrasonography, CT or MRI is
effective in more than 90% of cases. It should be differen-
tiated from other fat-containing adrenal masses such as
teratoma, lipoma and liposarcoma. The optimal treatment
depends on the size and symptoms of the tumor. Surgical
treatment is usually not necessary for asymptomatic
adrenal myelolipomas smaller than 4 cm. In contrast,
symptomatic, complicated, and hormonally active myeloli-
pomas larger than 7 cm should be surgically removed.
This report present a 50-year old adult raised as a male
with giant adrenal myelolipomas manifested as adrenal
masses, which was misdiagnosed with liposarcoma by
radiologic examination. The patient has been raised as
male despite of ambiguous genitalia and thorough
investigation was not performed because of poor socioeco-
nomic status. Physical examination showed short stature
(<3rd percentile), hyperpigmentation, and micropenis
without palpable gonads. There were uterus and ovary in
pelvic cavity on abdominopelvic CT. ACTH stimulation
test showed adrenal insufficiency. Steroid replacement
was initiated before bilateral adrenalectomy. The histologic
findings revealed myelolipomas, and endocrine and
molecular investigation lead to the diagnosis of
21-hydroxylase deficiency. Karyotype was 46,XX and
mutation analysis of CYP21A2 identified a compound
heterozygosity consisting of p.I173N and p.Q319*. The
patient has been treated with dexamethasone 0.5 mg once
daily and fludrocortisone 0.1 mg once daily. As subject has
been raised as a male, additional operation such as
oophoro-hysterectomy is under consideration. Patients
with congenital adrenal hyperplasia should be screened for
incidental adrenal masses to avoid unnecessary surgical
procedures.
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